Physician profile
Joseph E Asuncion
NPI 1225009400
$13,182.58
in general payments reported to CMS, 2019-2025
32 companies · $4,484 in 2025
The $4,484 reported for 2025 was more than what 99% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $587 · 2020: $365 · 2021: $255 · 2022: $219 · 2023: $1,248 · 2024: $6,025 · 2025: $4,484.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,413 · Food and Beverage: $5,299 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,412.50 |
| Food and Beverage | $5,299.03 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $7,055.21 | 2024-2025 | Voquezna |
| Astrazeneca Pharmaceuticals LP | $2,058.51 | 2020-2025 | Farxiga, Airsupra, Breztri |
| Novo Nordisk INC | $932.52 | 2020-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $691.29 | 2019-2025 | |
| Amgen INC. | $367.16 | 2023-2025 | Evenity, Otezla, Repatha |
| Glaxosmithkline, LLC. | $199.88 | 2019-2024 | Shingrix, Arexvy, Trelegy Ellipta |
| Exact Sciences Corporation | $196.70 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $190.19 | 2023-2025 | Jardiance |
| Lilly USA, LLC | $189.21 | 2023-2025 | Mounjaro, Jardiance, Zepbound |
| Astellas Pharma US INC | $163.45 | 2023-2025 | Veozah |
| Merck Sharp & Dohme LLC | $106.39 | 2019-2024 | Gardasil 9, Gardasil, Capvaxive |
| Horizon Therapeutics Plc | $106.30 | 2023 | Krystexxa |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $96.52 | 2019-2020 | |
| Esperion Therapeutics, INC. | $75.08 | 2021-2025 | Nexletol |
| Janssen Pharmaceuticals, INC | $70.95 | 2019 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $65.76 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $64.00 | 2019-2023 | Eliquis |
| Eisai INC. | $63.45 | 2020 | |
| Abbvie INC. | $60.44 | 2023-2025 | Vraylar |
| Kvk-Tech, INC. | $58.22 | 2025 | |
| Medtronic, INC. | $49.08 | 2024-2025 | Minimed 780g, Intellis Adaptivestim |
| Teva Pharmaceuticals USA, INC. | $43.36 | 2019 | |
| Idorsia Pharmaceuticals US INC | $40.88 | 2023 | Quviviq |
| Lifescan, INC. | $39.09 | 2020 | |
| Novartis Pharmaceuticals Corporation | $36.67 | 2019-2020 | |
| Cranial Technologies, INC | $31.65 | 2020-2025 | Doc Band |
| Kowa Pharmaceuticals America, INC. | $29.00 | 2024-2025 | Zoryve |
| Inspire Medical Systems, INC. | $26.68 | 2025 | Inspire |
| Tms Neurohealth Centers INC. | $25.07 | 2025 | Tms Neurohealth Centers INC. |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $17.71 | 2024 | Caplyta |
| Abbott Laboratories | $16.96 | 2023 | Freestyle Libre 3 |
| Stability Biologics, LLC | $15.20 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Asuncion listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.